Safety and efficacy of remimazolam in critical illness
Crossref DOI link: https://doi.org/10.1186/s40560-026-00857-8
Published Online: 2026-01-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Obara, Shinju
Yoshida, Keisuke
Inoue, Satoki
Text and Data Mining valid from 2026-01-23
Version of Record valid from 2026-02-16
Article History
Received: 30 December 2025
Accepted: 20 January 2026
First Online: 23 January 2026
Declarations
:
: Not applicable.
: The authors declare no competing interest.